p53 functions as a negative regulator of osteoblastogenesis, osteoblast-dependent osteoclastogenesis, and bone remodeling. - Test2 - elhamkhani - TriplyDB

p53 functions as a negative regulator of osteoblastogenesis, osteoblast-dependent osteoclastogenesis, and bone remodeling.

p53 functions as a negative regulator of osteoblastogenesis, osteoblast-dependent osteoclastogenesis, and bone remodeling.

http://www.wikidata.org/entity/Q36116766

about

Fibrillin-1 and -2 differentially modulate endogenous TGF-β and BMP bioavailability during bone formation P53 functional abnormality in mesenchymal stem cells promotes osteosarcoma development Molecular Aspects of Bone Resorption in β-Thalassemia Major Cell Death in Chondrocytes, Osteoblasts, and Osteocytes Protein palmitoylation regulates osteoblast differentiation through BMP-induced osterix expression Identification of genes for complex diseases using integrated analysis of multiple types of genomic data.Identification and characterization of microRNAs by high through-put sequencing in mesenchymal stem cells and bone tissue from mice of age-related osteoporosis.Lentiviral arrays for live-cell dynamic monitoring of gene and pathway activity during stem cell differentiation.p53 plays a role in mesenchymal differentiation programs, in a cell fate dependent manner Mouse models of p53 functions.The ARF tumor suppressor regulates bone remodeling and osteosarcoma development in mice.Time series gene expression profiling and temporal regulatory pathway analysis of BMP6 induced osteoblast differentiation and mineralization.p53 at a glance.Identification of genes for complex diseases by integrating multiple types of genomic data.Extracellular microfibrils control osteoblast-supported osteoclastogenesis by restricting TGF{beta} stimulation of RANKL production Elevated expression of Runx2 as a key parameter in the etiology of osteosarcoma.Ablation of Tak1 in osteoclast progenitor leads to defects in skeletal growth and bone remodeling in mice.Osteosarcoma in Paget's disease of bone.Microgravity induces pelvic bone loss through osteoclastic activity, osteocytic osteolysis, and osteoblastic cell cycle inhibition by CDKN1a/p21.Loss of the osteogenic differentiation potential during senescence is limited to bone progenitor cells and is dependent on p53.Gene expression profiles resulting from stable loss of p53 mirrors its role in tissue differentiation.Overexpression of the PLAP-1 gene inhibits the differentiation of BMSCs into osteoblast-like cells.p53 loss increases the osteogenic differentiation of bone marrow stromal cells p53 in stem cells Fibulin-1 is required for bone formation and Bmp-2-mediated induction of Osterix.Modeling familial cancer with induced pluripotent stem cells The impact of osteoblastic differentiation on osteosarcomagenesis in the mouse.Pannexin 3 functions as an ER Ca(2+) channel, hemichannel, and gap junction to promote osteoblast differentiation.Transcriptional Profiling of Laser Capture Microdissected Subpopulations of the Osteoblast Lineage Provides Insight Into the Early Response to Sclerostin Antibody in Rats.Ascorbic acid regulates osterix expression in osteoblasts by activation of prolyl hydroxylase and ubiquitination-mediated proteosomal degradation pathway Cre-mediated recombination can induce apoptosis in vivo by activating the p53 DNA damage-induced pathway Ethanol impairs estrogen receptor signaling resulting in accelerated activation of senescence pathways, whereas estradiol attenuates the effects of ethanol in osteoblasts.Age-related BMAL1 change affects mouse bone marrow stromal cell proliferation and osteo-differentiation potential.p53 and MDM2 are involved in the regulation of osteocalcin gene expression.Signaling networks that control the lineage commitment and differentiation of bone cells.Impairment of osteoblast differentiation due to proliferation-independent telomere dysfunction in mouse models of accelerated aging Attenuation of WNT signaling by DKK-1 and -2 regulates BMP2-induced osteoblast differentiation and expression of OPG, RANKL and M-CSF Skeletons in the p53 tumor suppressor closet: genetic evidence that p53 blocks bone differentiation and development Adenovirus-mediated p53 tumor suppressor gene therapy of osteosarcoma.The mysterious human epidermal cell cycle, or an oncogene-induced differentiation checkpoint.

P2860

Q24300318-8B5F25D9-7692-4E59-B7DA-54E9971DDE64 Q26771603-05E45166-4366-4D21-BCB0-A9362A2AA9D8 Q26801066-FB2C87C4-3C10-4E1F-8B07-155968C51199 Q28067045-11A777B9-CF25-468E-A1FF-921143B213C9 Q28474460-14BB5B0A-9839-4DBE-9505-5AA2273208A8 Q30562778-621068FD-3E92-49BD-9577-739FA92B5B32 Q31131903-3E9DF0E4-013D-480C-8557-EE9AC997E0C0 Q31162474-6802EA59-2061-47BB-BA16-C8CD94ED543E Q33383860-31B143CD-616C-4896-BF01-DF2E9D28D2F8 Q33752174-06447865-20D7-43B3-844E-D2D6E3C920C6 Q33786905-EB625396-91FB-4E6D-966F-24CD2D781B89 Q33909410-84EC0C90-02E5-4D29-A8F2-E55E57A34F57 Q34029735-A652E739-0699-4B93-A781-02241A14059B Q34181829-81A0EAE6-1606-4FC1-B8F5-F21F74C0156F Q34232152-A1158ADC-42FD-44B7-823C-31ECB13B0929 Q34308600-31E3089A-DF7B-406C-9E52-EC87C7F6556E Q34561579-24D0F30A-C641-4F21-8A89-9D22E76D926B Q34574123-125F3BBA-5E59-415C-835E-0556B0B60359 Q34700233-36F64FA9-A8D8-4E2E-8FD0-9B069E78BC0E Q34979749-494ED040-1139-4614-8098-DB7C5DB259D3 Q35060929-D5E9ED9E-00A6-4854-A73B-BEBC6557BF12 Q35209241-36B27577-6A91-41C1-AD5B-916598CFDBC6 Q35224427-A17E058A-A181-4B35-823D-4FFDF2CDE94F Q35228392-AA316E66-BA46-4D03-AE48-5305EE658241 Q35267375-2B334A26-12D4-4A74-9B6B-5C068303C1B8 Q35428604-ED374BC8-C4C5-450D-9AA0-9F15353C9960 Q35542888-49722F2C-A861-4486-91A7-559478B22732 Q35550768-CDDC5667-39E8-4EF5-BA15-2FE974A967FC Q35560337-4487FE06-9F4E-4BBF-99CA-3D82DD6F90C8 Q35696053-43C02E8A-2CF0-4E9C-BC11-4D9CA7A3D886 Q35740259-E4ECA4A5-B5E6-4A6E-926C-C81B4A1B1C3E Q35747409-82E81C03-6C1C-426A-A731-F0D4272184F6 Q35843920-3F0E0253-8D30-495A-8F76-A8894FCE4E67 Q35871217-678EDEB9-FFC1-4C12-A746-B4DFD34C83D2 Q36082866-B2B6F8AB-3933-4FBB-BA2D-A34DE014795F Q36103691-2514F556-2C96-4F5D-A6EC-813537F9FCBE Q36325366-0358061F-AB89-45EC-8AC0-F8FC5ADA049C Q36420116-2C1EBBD5-EFB0-4D63-A04B-A0FECDCF40AF Q36496709-4C664810-2F8A-48B5-BC90-10352164F0B7 Q36581649-A37FF339-87CE-412C-ABA7-865C11B1EFF9

P2860

p53 functions as a negative regulator of osteoblastogenesis, osteoblast-dependent osteoclastogenesis, and bone remodeling.

http://www.wikidata.org/entity/Q36116766

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

p53 functions as a negative re ...... ogenesis, and bone remodeling.

@ast

p53 functions as a negative re ...... ogenesis, and bone remodeling.

@en

type

label

p53 functions as a negative re ...... ogenesis, and bone remodeling.

@ast

p53 functions as a negative re ...... ogenesis, and bone remodeling.

@en

prefLabel

p53 functions as a negative re ...... ogenesis, and bone remodeling.

@ast

p53 functions as a negative re ...... ogenesis, and bone remodeling.

@en

P1433

Q36116766-AB274E23-8A99-4519-9A15-F936499142AC

P1476

Q36116766-C32664AF-A523-4195-BBDC-C008494CFF7E

P2093

Q36116766-05A2170F-5081-4CF3-8A49-2C9FA4754048

Q36116766-66330569-8EFC-46B8-8841-5D013219D6A7

Q36116766-6D44D05D-F403-4A18-B251-ED688EE42941

Q36116766-74E08143-6D7E-4538-AC23-9C9828C43127

Q36116766-87078D8E-CDD2-42B8-A233-F69F0A4F46D0

Q36116766-A4042B14-F0EC-49F1-AAE2-568D76CF4C6E

Q36116766-BF5BACF5-838F-4941-9461-75BB6F4C434E

Q36116766-C0C39B9A-9074-4039-8B75-E0D4B0A55047

Q36116766-CCD41B73-E56C-4429-88F4-7E5693D4A5AB

Q36116766-ECCE8C2E-AE30-4F62-AE5F-D610CB678E27

P2860

Q36116766-024C8550-9BA0-4A4E-B2E6-1776B5DC06C8

Q36116766-0B8C7162-915E-4033-BA38-9374D29F8738

Q36116766-0D350783-9282-41A1-90AB-A16DCC18B462

Q36116766-0D5C9C11-CBA5-447E-9F27-BA411FC7B189

Q36116766-1208050D-5DF5-4283-BB44-C19CE57BA65C

Q36116766-18C05AD7-6CE1-465D-AAFF-5D6C8BBFAB0E

Q36116766-2618A9BC-6698-4F7E-B211-76A7E3650258

Q36116766-32B4BBFB-F6EF-4851-9E92-5CC1C7630FF0

Q36116766-35A410EE-7BA3-4F26-925B-2CF35503318A

Q36116766-35A57C74-4056-4F24-8169-EA84215A5915

P304

Q36116766-CA53BA96-4DD9-4DDC-A515-5146BEF19740

P31

Q36116766-AF029700-B318-45D3-AB39-3724CC791C06

P356

Q36116766-285E1D1E-9E66-49A3-ACD8-E56C61C4180B

P407

Q36116766-F15B2F5E-327F-4FAD-818C-CE09C8334B71

P433

Q36116766-85120867-6FA1-4531-A3D3-801BE25A7919

P478

Q36116766-73F39D0F-8061-40A2-95E5-60F274834577

P50

Q36116766-7DB142A8-B2F9-4089-9072-B09C6B950210

P577

Q36116766-EE767107-CF29-4AC9-BD9C-7D531EA5077E

P5875

Q36116766-0C47CCE5-04B7-4B2C-9889-92354FF5BD33

P698

Q36116766-B95708C0-AC7A-4FAF-BA20-541466847CCA

P921

Q36116766-F6D4C0A3-214F-41F0-BE5F-AEF20857DC50

P932

Q36116766-E46F7B65-9CA1-495F-90E2-389966558479

P356

P1433

Journal of Cell Biology

P1476

p53 functions as a negative re ...... ogenesis, and bone remodeling.

@en

P2093

Baojie Li

http://www.w3.org/2001/XMLSchema#string

Benoit de Crombrugghe

http://www.w3.org/2001/XMLSchema#string

Gerard Karsenty

http://www.w3.org/2001/XMLSchema#string

Hui-Yi Kua

http://www.w3.org/2001/XMLSchema#string

James Yeh

http://www.w3.org/2001/XMLSchema#string

Ke Guo

http://www.w3.org/2001/XMLSchema#string

Qi Zeng

http://www.w3.org/2001/XMLSchema#string

Qiang Wu

http://www.w3.org/2001/XMLSchema#string

Xueying Wang

http://www.w3.org/2001/XMLSchema#string

Yuanyu Hu

http://www.w3.org/2001/XMLSchema#string

P2860

p53 in embryonic development: maintaining a fine balance

The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation

The requirement for the p53 proline-rich functional domain for mediation of apoptosis is correlated with specific PIG3 gene transactivation and with transcriptional repression.

Repression of RNA polymerase I transcription by the tumor suppressor p53

Surfing the p53 network

Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families

Diversified transcription initiation complexes expand promoter selectivity and tissue-specific gene expression

CREB-binding protein and p300 in transcriptional regulation

Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation

The complexity of p53 modulation: emerging patterns from divergent signals

P304

115-125

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1083/JCB.200507106

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

172

http://www.w3.org/2001/XMLSchema#string

P50

P577

2005-12-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7391816

http://www.w3.org/2001/XMLSchema#string

P698

16380437

http://www.w3.org/2001/XMLSchema#string

P921

P932

2063539

http://www.w3.org/2001/XMLSchema#string